Sign in Join
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Sign in
Welcome!Log into your account
Forgot your password?
Sign up
Welcome!Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
Search
  • Sign in / Join
  • My Account
  • orders
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Home SEC Filings OMNOVA Solutions Inc. (NYSE:OMN) Files An 8-K Other Events
  • SEC Filings

OMNOVA Solutions Inc. (NYSE:OMN) Files An 8-K Other Events

By
ME Staff 8-k
-
January 15, 2020
Share on Facebook
Tweet on Twitter

OMNOVA Solutions Inc. (NYSE:OMN) Files An 8-K Other Events
Item 8.01

On July 3, 2019, OMNOVA Solutions Inc. (the \”Company\”) announced it had entered into an Agreement and Plan of Merger with Synthomer plc (\”Synthomer\”), Spirit USA Holdings Inc., and Synthomer USA LLC, to which the Company would merge with and into Spirit USA Holdings Inc., a wholly-owned subsidiary of Synthomer, subject to shareholder and regulatory approvals and other customary conditions (the \”Transaction\”).>>
As contemplated by the merger agreement, on November 15, 2019, Synthomer notified the European Commission that it was seeking approval of the Transaction. On January 15, 2020, Synthomer and the Company received confirmation from the European Commission that it had conditionally approved the Transaction.
A copy of the Company\’s press release announcing the European Commission\’s decision is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Forward-Looking Statements
Forward-looking statements within this disclosure are being made in reliance upon the safe harbor of the Private Securities Litigation Reform Act of 1995, including, without limitation, the statements made concerning the Company’s intent to consummate the Transaction with Synthomer. As a general matter, forward-looking statements are those focused upon anticipated events or trends, expectations, and beliefs relating to matters that are not historical in nature. Such forward-looking statements are subject to uncertainties and factors relating to the Company’s operations and business environment, all of which are difficult to predict and many of which are beyond the control of the Company. Among others, the following uncertainties and other factors could cause actual results to differ from those set forth in the forward-looking statements: (i) the risk that the Transaction may not be consummated in a timely manner, if at all; (ii) the risk that the definitive merger agreement may be terminated in circumstances that require the Company to pay Synthomer a termination fee; (iii) risks related to the diversion of management’s attention from the Company’s ongoing business operations; (iv) the effect of the announcement of the proposed Transaction on the Company’s business relationships (including, without limitation, customers and suppliers), operating results and business generally; (v) risks related to obtaining the requisite consents to the proposed Transaction, including, without limitation, the receipt of approval from the Company’s shareholders, the timing (including possible delays) and receipt of regulatory clearance from governmental authorities (including any conditions, limitations or restrictions placed on these approvals) and the risk that one or more governmental authority may deny any such approval; and (vi) the conditions of the capital markets during the period covered by the forward-looking statements. Further risks that could cause actual results to differ materially from those matters expressed in or implied by such forward-looking statements are set forth under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2018, and its subsequent quarterly reports on Form 10-Q. The Company does not undertake, and hereby disclaims, any duty to update these forward-looking statements, although its situation and circumstances may change in the future.
(c) Exhibits
OMNOVA SOLUTIONS INC Exhibit
EX-99.1 2 a1152020pressrelease.htm PRESS RELEASE,…
To view the full exhibit click here

Story continues below

About OMNOVA Solutions Inc. (NYSE:OMN)

OMNOVA Solutions Inc. (OMNOVA) is a provider of emulsion polymers, specialty chemicals and engineered surfaces for commercial, industrial and residential end uses. The Company operates in two segments: Performance Chemicals and Engineered Surfaces. OMNOVA Performance Chemicals segment produces a range of emulsion polymers and specialty chemicals based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, nitrile butadiene (NBR), polyvinyl acetate, acrylic, styrene acrylic, vinyl acrylic, glyoxal, fluorochemical and bio-based chemistries. The Company’s Engineered Surfaces segment develops, designs, produces and markets a line of functional and decorative surfacing products, including coated fabrics, vinyl, paper and specialty laminates, and performance films. It operates production facilities in the United States, Europe, China and India.

An ad to help with our costs
SHARE
Facebook
Twitter
ME Staff 8-k

RELATED ARTICLESMORE FROM AUTHOR

COHERUS BIOSCIENCES, INC. (NASDAQ:CHRS) Files An 8-K Entry into a Material Definitive Agreement

Ciner Resources LP (NYSE:CINR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain...

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain...

Torchlight Energy Resources, Inc. (NASDAQ:TRCH) Files An 8-K Entry into a Material Definitive Agreement

EP ENERGY CORPORATION (NYSE:EPE) Files An 8-K Regulation FD Disclosure

Mercury Systems, Inc. (NASDAQ:MRCY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain...

A word from the sponsor
Latest Articles
  • LIBERTY BROADBAND CORPORATION (NASDAQ:LBRDA) Files An 8-K Regulation FD Disclosure
  • REGENCY CENTERS CORPORATION (NYSE:REG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • ASSURED GUARANTY LTD. (NYSE:AGO) Files An 8-K Results of Operations and Financial Condition

Recent Posts

  • OMNOVA Solutions Inc. (NYSE:OMN) Files An 8-K Other Events
  • COHERUS BIOSCIENCES, INC. (NASDAQ:CHRS) Files An 8-K Entry into a Material Definitive Agreement
  • Ciner Resources LP (NYSE:CINR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Torchlight Energy Resources, Inc. (NASDAQ:TRCH) Files An 8-K Entry into a Material Definitive Agreement
Sponsored
/* */

EDITOR PICKS

bitcoin

Market Morning: Trade Deal Signing, Bitcoin Fracas, Trump Rages at Apple,...

January 15, 2020
Samsung-fire-news

Market Morning: Iran Protests, Boeing Embarrasses Self, Australia Evacuates, GrubHub Rollup

January 13, 2020
Tesla

Market Morning: Bernanke Goes Negative, Apple App Bonanza, Tesla To the...

January 9, 2020

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings90730
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019
// AST – IMS - [MarketExclusive_ROS]